Navigation Links
Loss in Biological Technology

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

... income due to lower cash balances. Net loss decreased 26%, or $540,603 to $1.6 million for ... million for the same period in 2008 and the net loss for the six months ended June 30, 2009, decreased ... or $628,477 to $3.5 million, compared with a net loss of $4.1 million for the same period in 2008. ...

Novavax Reports Second Quarter 2009 Financial Results

... Inc. (Nasdaq: NVAX ) today reported a net loss of $8.5 million, or $0.10 per share, for the second quarter of 2009 compared to a net loss of $9.4 million, or $0.15 per share, for the ... ended June 30, 2009, Novavax reported a net loss of $16.9 million, or $0.22 per share, as compared ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

... ended June 30, 2009, the Company reported a net loss of $1,761,887, or $0.13 per basic and diluted share, compared to a net loss of $2,377,440, or $0.19 per basic and diluted ... ended June 30, 2009, the Company reported a net loss of $4,793,088, or ...

NeurogesX Reports Second Quarter 2009 Results

... the United States and European Union. Net loss for the second quarter of 2009 was approximately $5.4 million, compared to a net loss of approximately $6.9 million for the second quarter of 2008. Net loss per share attributable to common stockholders was ...

AutoImmune Inc. Reports 2009 Second Quarter Financial Results

... (OTC Bulletin Board: AIMM) today reported a net loss of $86,000, or $0.01 per share basic and diluted, ... months ended June 30, 2009, compared with a net loss of $86,000, or $0.01 per share basic and diluted, ... For the six months ended June 30, 2009, the net loss was $256,000, or $0.02 per share basic and ...

Microbix Sales Grow 22% For Nine Months

... ended June 30, 2009, the Company recorded a net loss of $672,366 or one cent a share compared to a loss of $945,111 or three cents a share in the same ... $ 1,079,492 in the same period in 2008. A lower loss for the third quarter compared to 2008 reflected ...

GenVec Reports Second Quarter 2009 Financial Results

... ) GenVec reported a net loss of $4.8 million ($0.05 per share) for the three months ended June 30, 2009 compared to a net loss of $6.6 million ($0.08 per share) in the ... the six months ended June 30, 2009, GenVec's net loss was $10.5 million ($0.12 per share), compared to ...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

... ended June 30, 2009. InterMune reported a net loss for the second quarter of 2009 of $36.7 million, or $0.81 per share, compared with a net loss of $29.6 million, or $0.76 per share, in the ... of pirfenidone. InterMune recorded a loss on extinguishment of debt of $9.5 million, of ...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

... expense related to FAS123(R). Net loss for the second quarter of 2009 was $20.2 million, ... 2008. The number of shares used to calculate net loss per share was 61,137,755 for this period versus ... expense related to FAS123(R). Net loss for the first six months of 2009 was $37.7 ...

OncoGenex Reports Second Quarter 2009 Financial Results

... results of OncoGenex thereafter. The loss attributable to common shareholders for the ... 2008. For the six months ended June 30, 2009 the loss attributable to common shareholders increased to ... ------------------ ------------------ loss for the period before taxes 4,557 1,967 ...

Telik Announces Second Quarter 2009 Financial Results

... Inc. (Nasdaq: TELK ) today reported a net loss of $5.7 million, or $0.11 per share, for the ... quarter ended June 30, 2009, compared with a net loss of $13.6 million, or $0.26 per share, for the ... months ended June 30, 2009, Telik reported a net loss of $13.4 million, or $0.25 per share, compared ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... costs were $19.0 million. - GAAP net loss and net loss per share for the quarter were ($11.9) ... and ($0.14), respectively. - Adjusted net loss and adjusted ...

Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

... of CTI's Bresso, Italy research facility. Net loss attributable to common shareholders decreased by ... million ($0.06 per share), compared to a net loss attributable to common shareholders of $59.3 ... for the same period in 2008. The reduction in net loss per share is due to an increase in the number of ...

Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results

... or $0.29 per diluted share, compared to a net loss of $7.7 million, or $0.17 per share, for the ... or $0.30 per diluted share, compared to a net loss of $42.2 million, or $0.96 per share, for the ... 14,132 (7,689) 14,583 (42,144) loss from discontinued operations ...

PDI Reports 2009 Second Quarter Financial Results

... million benefit in 2009 due to a reduction in the loss contract accrual associated with the mutual ... in 2009 compared to 2008. Total operating loss for the second quarter of 2009 was $4.7 million ... to $7.9 million in the same period of 2008. Net loss per share for the second quarter of 2009 was ...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

... Principles (GAAP), Amicus announced a net loss attributable to common stockholders of $0.60 per ... & Notes On a reported basis, the net loss attributable to common stockholders for the three ... same period in 2008. On a non-GAAP basis, the net loss for the three months ended June 30, 2009, was ....

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

... ended June 30, 2009, Cadence reported a net loss of $8.3 million, or $0.17 per share, compared to a net loss of $15.6 million, or $0.41 per share, for the ... ended June 30, 2009, Cadence reported a net loss of $18.7 million, or $0.40 per share, compared to ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... in Q2 2009 was $35 million, compared to a loss of $67 million in 2008. - Non GAAP diluted ... for INTUNIV. The US GAAP operating loss from continuing operations in Q2 2008 included ... loss). Discontinued operations The loss from discontinued operations for the three months ...

Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results

... ended June 30, 2009. Optimer reported a net loss for the second quarter of 2009 of $12.4 million, ... Company's expectations. This compares to a net loss for the second quarter of 2008 of $8.1 million, or $0.29 per share. The increase in net loss was primarily due to higher research and ...

NxStage Reports Second Quarter 2009 Financial Results

... percent in the second quarter of 2008. Net loss for the second quarter of 2009 was $12.5 million, ... facility, recorded as interest expense, the net loss for the second quarter of 2009 was better than the Company's second quarter guidance for a net loss of $11.5 to $12.5 million. This compares to a ...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

... Financial Results The Company reported a net loss of $9.7 million ($0.28 diluted loss per share on a loss applicable to common shares of $9.8 million) for ...

Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress

... in the second quarter of 2008. Net loss decreased to $3.9 million in the second quarter ... the second quarter of 2008. Basic and diluted net loss per share was $0.14 in the second quarter of 2009, compared with basic and diluted net loss per share of $0.15 in the second quarter of 2008. ...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

... the second quarter financial results for net loss and cash utilization were in-line with the ... expenses and travel expenses. The net loss for the second quarter of 2009 was $0.26 per share, compared to a net loss of $0.25 per share for the second quarter of ....

Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights

... of 2009 and 2008, respectively. The net loss was $6.5 million for the second quarter of 2009, compared to a net loss of $7.1 million for the second quarter of 2008. Included in the net loss for the second quarter of 2009 is a $0.4 million ...

Caliper Life Sciences Reports Second Quarter 2009 Results

... 3%, respectively. The Company narrowed its net loss to $4.1 million ($0.08 per share) in the second quarter of 2009, from a net loss of $6.7 million ($0.14 per share) in the same ... as of June 30, 2009. Reduced adjusted net loss per share to $0.05 per share compared to $0.09 ...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

... and six months ended June 30, 2009, compared to a loss per share of $0.05 and $1.52 in the same prior ... the six months ended June 30, 2009, compared to a loss from operations of $297.5 million in the same ... 80,753 132,853 164,599 Impairment loss on goodwill - ...

Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results

... Inc. CONSOLIDATED STATEMENTS OF loss AND COMPREHENSIVE LOSS ... loss before the following: 4,338,489 ... - - - loss on sale of Transition Therapeutics Inc. ...

Sangamo BioSciences Reports Second Quarter 2009 Financial Results

... 30, 2009, Sangamo reported a consolidated net loss of $4.5 million, or $0.11 per share, compared to a consolidated net loss of $7.4 million, or $0.18 per share, for the same ... months ended June 30, 2009, the consolidated net loss was $11.3 million, or $0.28 per share, compared ...

Neurocrine Biosciences Reports Second Quarter 2009 Results

... quarter of 2009, the Company reported a net loss of $15.3 million, or $0.39 per share, compared with a net loss of $21.0 million, or $0.55 per share, for the ... ended June 30, 2009, the Company reported a net loss of $34.9 million, or $0.90 per share, as compared ...

Sunesis Reports Financial Results for the Second Quarter 2009

... quarter of 2009 was $3.5 million, with a net loss of $22.9 million, including non-cash charges of ... related to the financing completed in April. loss from operations was $1.9 million for the second ... ---------- ---------- ---------- loss from operations (1,931,620) ...

Cynosure Reports Second Quarter 2009 Financial Results

... sales prices. Cynosure reported a net loss for the second quarter of 2009 of $2.3 million, ... share, in the second quarter of 2008, and a net loss of $4.0 million, or $0.32 per basic and diluted ... with 66.8% for the same period in 2008. Net loss for the first half of 2009 was $6.3 million, or ...

Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results

... the second quarter of 2008. Idenix reported a net loss of $16.3 million, or a loss of $0.28 per basic and diluted share, for the second quarter ended June 30, 2009, compared to a net loss of $18.9 million, or ...

BioMS Medical announces second quarter 2009 results

... $0.02 per share compared with a consolidated net loss of ($0.4) million or ($0.00) per share for the ... $0.00 per share compared with a consolidated net loss of ($7.1) million or ($0.08) per share for the ... 85 43 42 31 loss on disposal of property and ...

Vasogen Announces Second Quarter 2009 Results

... acquired, dissolved, or liquidated. The net loss for the second quarter of 2009 was $1.4 million, or $0.06 per common share, compared with a net loss of $7.4 million, or $0.33 per common share for the same period in 2008. The $1.4 million loss for the three months ended May 31, 2009 included ...

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

... period 1 January to 30 June 2009. - The loss after tax realised in the 2nd quarter of 2009 ... Statement (1 January - 30 June 2009) The loss after tax realised in the 2nd quarter of 2008 was ... to 29,8m DKK (4,0m EUR) in 2008. The accumulated loss after tax for the first half of 2009 was 34,5m ...

Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity

... doses, experienced significantly more weight loss on average (11%; 22 pounds, p<0.01) than those ... role of leptin in regulating body fat, the weight loss in these patients was predominantly due to a ... combination arms achieved more weight loss than placebo. The magnitude of ...

Amgen to Participate in Reproductive Health Drugs Advisory Committee Meeting in August

... osteoporosis and prevention and treatment of bone loss in patients undergoing hormone ablation for ... breast cancer who are at increased risk for bone loss and consequently fracture. We look forward to ... women, and treatment and prevention of bone loss in patients undergoing hormone ablation for ...

Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update

... to the same period in the previous year loss for the period The Company recorded a loss of $4,134,000 and $10,707,000 respectively, for ... nine month periods ended April 30, 2009, for a loss per common share of $0.08 and $0.21, ....

Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions

... previously reported results on the primary weight loss endpoints and measures of cardiometabolic risk. ... show that Contrave initiates and sustains weight loss and can improve predictive markers for heart ... The trial evaluated the additional weight loss of Contrave (32mg naltrexone SR/360mg bupropion ...

Data on VIVUS' Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting

... Previous studies have shown significant weight loss with Qnexa treatment. Both podium presentations will highlight the benefit of weight loss and the corresponding positive impact on type 2 ... phase 3 EQUATE trial (OB-301) shows that weight loss with Qnexa stops the progression of type 2 ...
Other Contents
(Date:3/12/2015)... WINSTON-SALEM, N.C. , March 12, 2015 ... afternoon at Brenner Children,s Hospital, part of Wake Forest ... an outreach initiative for the 2015 ACC Men,s Basketball ... taking pictures with them and getting their autographs. ... Wake Forest Baptist. It is the only children,s hospital ...
(Date:3/11/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) has ... by Product, Application & By Geography - Global Forecast ... , This report predicts that the access ... 2020, with an estimated CAGR of 10.6%. ... such as contact cards & readers, contactless cards & ...
(Date:3/10/2015)... Colo. , March 10, 2015 ... Flight "Personalized Medicine in Human Space ... and Thomas J. Goodwin , Ph.D. was recently ... of the past two years. Specifically, "Personalized ... most downloaded scientific papers published in 2013 and 2014 ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
(Date:3/27/2015)... On March 19, 2015, at ... Lions wide receiver Herman Moore, hosted “Fighting Addiction ... substance abuse, treatment options and the recent changes ... pastors, ministers and bishops from local churches as ... , “Our ‘Fighting Addiction Together’ luncheon was informative ...
(Date:3/27/2015)... 27, 2015 SMI (Silicon Microstructures, Inc.), ... has launched the SM1120 MEMS based ultra-miniature pressure sensor ... microsensor profile at only 220um x 75um provides ample ... challenging locations. With industry leading in vivo drift ... provides a broad operating pressure range from 0 to ...
(Date:3/27/2015)... Orange, CT (PRWEB) March 27, 2015 Trail ... go, after a workout, on weekend hikes and during the ... health benefits. Aurora Natural is proud to introduce a new ... your taste buds. Deliciously rich and flavorful selections packed with ... nuts, seeds, dried fruit and grains that add protein and ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Airy Jeanine ... released the official music video for her debut song ... , Combining live-action and abstract styling effects, the thematic ... viewed on YouTube, Vimeo, and assorted outlets. It will ... development of an expanding full-scale marketing strategy. The video ...
(Date:3/27/2015)... 27, 2015 Yisrayl Hawkins, Pastor and Overseer ... only way to live in Peace is through the Laws ... article published this week. , The article titled, “Yahweh’s Way-The ... mankind and how straying away from the original biblical instructions ... the system that has been created in the world is ...
Breaking Medicine News(10 mins):Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2
Other TagsOther Tags